arms/forearms itching; less hives returned on both arms/forearms; hives on both arms/forearms; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on both arms/forearms), PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hives (allergic reaction; over 50 years ago.), Duodenogastric reflux since an unknown date and Hypertension since an unknown date. Concurrent medical conditions included Drug allergy (Penicillin). Concomitant products included BUPROPION, VITAMIN D3 and OMEPRAZOLE for an unknown indication.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 19-Jan-2021, the patient experienced URTICARIA (hives on both arms/forearms). On 22-Jan-2021, the patient experienced PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of Topical cream and CALENDULA OFFICINALIS (AFTER BITE [CALENDULA OFFICINALIS]) at a dose of Topical. On 19-Jan-2021, URTICARIA (hives on both arms/forearms) had resolved. At the time of the report, PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 22-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on both arms/forearms), PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hives (allergic reaction; over 50 years ago.), Duodenogastric reflux since an unknown date and Hypertension since an unknown date. Concurrent medical conditions included Drug allergy (Penicillin). Concomitant products included BUPROPION, VITAMIN D3 and OMEPRAZOLE for an unknown indication.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 19-Jan-2021, the patient experienced URTICARIA (hives on both arms/forearms). On 22-Jan-2021, the patient experienced PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of Topical cream and CALENDULA OFFICINALIS (AFTER BITE [CALENDULA OFFICINALIS]) at a dose of Topical. On 19-Jan-2021, URTICARIA (hives on both arms/forearms) had resolved. At the time of the report, PRURITUS (arms/forearms itching) and URTICARIA (less hives returned on both arms/forearms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.